News
SLNO
--
0.00%
--
Is Huttig Building Products (HBP) A Good Stock To Buy Now?
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshl...
Insider Monkey · 5d ago
Thinking about buying stock in Irving Resources, Soligenix, Exela Technologies, Soleno Therapeutics, or Onconova Therapeutics?
/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IRV, SNGX, XELA, SLNO, and ONTX.
PR Newswire - PRF · 06/10 12:30
IVR, RH, ASAN and EDU among premarket gainers
Medley Management (MDLY) +79%.Orbsat Corp (OSAT) +38%.Sphere 3D Corp. (ANY) +30%.Xinyuan Real Estate (XIN) +26% after announcing the completion of five newly constructed properties.Zivo Bioscience (ZIVO) +21%.China HGS Real Estate (HGSH)
Seekingalpha · 06/10 12:17
Syneos Health, Skillz among premarket losers' pack
Koss (KOSS) -14%.C3.ai (AI) -11% on FQ4 earnings release.Stealth BioTherapeutics (MITO) -11%.Express (EXPR) -11% on Q1 earnings releaseFireEye (FEYE) -10% after spins out FireEye Products business to Symphony for $1.2B.Bed Bath & Beyond (BBBY) -10%.PetMed ...
Seekingalpha · 06/03 12:34
Sector Update: Health Care
MT Newswires · 06/02 15:46
BriaCell Therapeutics, Constellation Pharmaceuticals leads healthcare gainers; iRhythm Technologies, Progenity among major losers
Gainers: BriaCell Therapeutics (BCTX) +151%, Constellation Pharmaceuticals (CNST) +67%, Soleno Therapeutics (SLNO) +46%, Stealth BioTherapeutics (MITO) +24%, Aerpio Pharmaceuticals (ARPO) +9%.Losers: iRhythm Technologies (IRTC) -18%, Progenity (PROG) -14%,...
Seekingalpha · 06/02 15:02
Soleno Stock Shoots Higher as Diazoxide Choline Gets US Orphan Drug Tag for Glycogen Storage Disease
Benzinga · 06/02 13:41
Soleno Therapeutics Receives Orphan Drug Designation from FDA for Diazoxide Choline for the Treatment of Glycogen Storage Disease Type 1a
Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted its investigation...
GlobeNewswire · 06/02 13:27
Midday Report: Wall Street Edges Higher Ahead of Jobs Report
MT Newswires · 06/02 12:49
BRIEF-Soleno Therapeutics Receives Orphan Drug Designation From FDA For Diazoxide Choline For The Treatment Of Glycogen Storage Disease Type 1A
reuters.com · 06/02 12:28
Soleno shares soar on FDA Orphan Drug status for Glycogen Storage Disease treatment
Soleno Therapeutics (SLNO) announces that the U.S. FDA has granted its investigational drug, DCCR (diazoxide choline) Extended-Release tablets, Orphan Drug designation for the treatment of Glycogen Storage Disease Type 1a
Seekingalpha · 06/02 12:23
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Benzinga · 06/02 12:07
Soleno Therapeutics Receives Orphan Drug Designation for Diazoxide Choline to Treat Glycogen Storage Disease Type 1a
MT Newswires · 06/02 08:45
Soleno Therapeutics to Host Webinar Highlighting DCCR for Treatment of Prader-Willi Syndrome at European Congress on Endocrinology 2021
Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that the Company will host a webinar highlighting DCCR (diazoxide choline) Ext...
GlobeNewswire · 05/21 12:00
Soleno Therapeutics To Participate In Oppenheimer Rare & Orphan Disease Summit May 21 At 1:15 p.m. ET
Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D.,
Benzinga · 05/20 12:01
Soleno Therapeutics to Participate in the Oppenheimer Rare & Orphan Disease Summit
REDWOOD CITY, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M...
GlobeNewswire · 05/20 12:00
Thinking about buying stock in LightPath Technologies, Minerva Neurosciences, Cerecor, Eloxx Pharmaceuticals, or Soleno Therapeutics?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LPTH, NERV, CERC, ELOX, and SLNO.
PR Newswire - PRF · 05/19 12:39
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13)
Benzinga · 05/14 11:59
26 Stocks Moving in Thursday's Pre-Market Session
Gainers Fuel Tech, Inc. (NASDAQ: FTEK) shares rose 26.3% to $2.45 in pre-market trading after the company reported upbeat results for its first quarter on Wednesday.
Benzinga · 05/13 11:01
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11)
Benzinga · 05/12 12:57
Webull provides a variety of real-time SLNO stock news. You can receive the latest news about SOLENO THERAPEUT through multiple platforms. This information may help you make smarter investment decisions.
About SLNO
Soleno Therapeutics, Inc., formerly Capnia, Inc., is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon monoxide (ETCO) Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief. The Company has developed the CoSense End-Tidal Carbon Monoxide Monitor that measures ETCO for the detection of dangerous hemolysis rates. The Infant Solutions product line, including the NeoPIP Infant Resuscitator Unit and accessories, is designed for controlled and accurate resuscitation of neonates and infants in the clinical environment. Serenz Nasal Relief is a hand-held nasal irrigator that uses carbon dioxide (CO2) gas to wash the nasal passages.